COVID-19 Resources

Overview of SARS-CoV-2 infection in adults living with HIV – Juan Ambrosioni et al, Lancet HIV, May 2021

SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study – Matthew A Spinelli et al, Lancet HIV, April 19, 2021

Mitigation strategies to safely conduct HIV treatment research in the context of COVID-19 – International AIDS Society

COVID-19 vaccines and people living with HIV – World Health Organization

COVID-19 Vaccines and People with HIV: Frequently Asked Questions – HIV Medicine Association

COVID 19 Real-Time Learning Network: HIV – The Infectious Diseases Society of America and U.S. Centers for Disease Control and Prevention

COVID-19 and People Living with HIV, Frequently Asked Questions – AIDS United, HIVMA, Latino Commission on AIDS, NASTAD, NMAC, Positive Women’s Network, Prevention Access Campaign, TransLatin@ Coalition, US PLHIV Caucus, and The Well Project

COVID-19 and HIV – AVAC

HIV and COVID-19 coinfection: case reports, retrospective cohorts and outcomes – Simon Collins, HIV i-Base, June 1, 2020

EACS & BHIVA Statement on risk of COVID-19 for people living with HIV (PLWH) – May 25, 2020

Children’s HIV Association (CHIVA) statement on COVID-19 and HIV – May 5, 2020

Interim Guidance for COVID-19 and Persons with HIV – U.S. Department of Health and Human Services, April 21, 2020

COVID-19:  Special Considerations for People Living with HIV – IDSA and HIVMA, April 17, 2020

What does COVID-19 mean for people living with HIV: online information – HIV i-Base, March 27, 2020

Journal Articles

When Epidemics Collide: Why People with HIV May Have Worse COVID-19 Outcomes and Implications for Vaccination – Virginia A. Triant and Rajesh T. Gandhi, Clinical Infectious Diseases, January 4, 2021

COVID-19 infection among people with HIV in New York City: A population-level analysis of linked surveillance data – Sarah L. Braunstein, Clinical Infectious Diseases, November 30, 2020

Elevated COVID-19 outcomes among persons living with diagnosed HIV infection in New York State: Results from a population-level match of HIV, COVID-19, and hospitalization databases – James M. Tesoriero et al, medRxiv, November 6, 2020

New pathogen, same disparities: why COVID-19 and HIV remain prevalent in U.S. communities of colour and implications for ending the HIV epidemic – Gregorio A Millett, Journal of the International AIDS Society, October 28, 2020

Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK): a prospective observational study – Anna Maria Geretti et al, Clinical Infectious Diseases, October 23, 2020

Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients with HIV and Coronavirus Disease-19 – Dima Dandachi et al, Clinical Infectious Diseases, September 9, 2020

Descriptive account of 18 adults with known HIV infection hospitalised with SARS-CoV-2 infection – Sara Madge et al, Sexually Transmitted Infections, September 2, 2020

SARS‐CoV‐2 infection in people living with HIV: a systematic review – Paola Costenaro et al, Reviews in Medical Virology, September 1, 2020

Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa – Andrew Boulle et al, Clinical Infectious Diseases, August 29, 2020

COVID-19 in Hospitalized Adults With HIV – Kate Stoeckle et al, Open Forum Infectious Diseases, August 1, 2020

Clinical Characteristics and Outcomes in People Living With HIV Hospitalized for COVID-19 – Noga Shalev et al, Clinical Infectious Diseases, May 30, 2020

A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois – Jessica P. Ridgway et al, AIDS Patient Care and STDs, May 29, 2020

COVID-19 in people with HIV – Zhe Xu, Chao Zhang and Fu-Sheng Wang, Lancet HIV, May 28, 2020

Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort – Pilar Vizcarra et al, Lancet HIV, May 28, 2020

Clinical Features and Outcome of HIV/SARS-CoV-2 Co-Infected Patients in the Bronx, New York City – Kulachanya Suwanwongse and Nehad Shabarek, Journal of Medical Virology, May 28, 2020

Gender and COVID-19

Gender and COVID-19 Resources – Gender and COVID-19 Working Group

Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission – Hannah Peckham et al, Nature Communications, December 9, 2020

Lack of consideration of sex and gender in clinical trials for COVID-19 – Emer Brady et al, medRxiv, September 14, 2020

People Who Use Drugs and Drug Service Providers

COVID‐19 Vulnerability Among People Who Use Drugs: Recommendations for Global Public Health Programs and Policies – Ian W. Holloway et al, Journal of the International AIDS Society, June 1, 2019

EMCDDA update on the implications of COVID-19 for people who use drugs (PWUD) and drug service providers – The European Monitoring Centre for Drugs and Drug Addiction

Syringe Services Programs (SSPs), Drug User Health, and COVID-19 – National Alliance of State and Territorial AIDS Directors (NASTAD)

Harm Reduction

Coronavirus and drug harm reduction – Transform Drug Policy Foundation

Resources for drug use and COVID-19 risk reduction – Vital Strategies

Correctional and Detention Facilities

COVID-19 Guidance for Correctional and Detention Facilities – CDC

Cheat Sheet: COVID-19 Vaccine Pipeline—AVAC

COVID Vax Tracker—AVAC

Tracking Public Investment in Global COVID-19 R&D – UAEM, SNMA, AMSA

COVID-19 Research Registry – American Society for Microbiology

COVID-19 Vaccine and Therapeutics Tracker – BioRender

COVID-19 Treatment and Vaccine Tracker – Milken Institute

STAT News COVID-19 Drugs and Vaccines Tracker

COVID-19 Clinical Trials Explorer – Jesse Burk Rafel, MD, MRes and Marina Marin, MS

Covid-19 TrialsTracker – The DataLab in collaboration with the Centre for Evidence-Based Medicine (CEBM) at the University of Oxford

Scientist.com Trial Tracker

COVID-19 Diagnostics In Context – Center for Systems Biology, Massachusetts General Hospital

SARS-CoV-2 Diagnostic Pipeline – FIND

SARS-CoV-2 Molecular Assay Evaluation: Results

Emergency Use Authorized Serology Test Performance – US Food and Drug Administration

IDSA COVID-19 Antibody Testing Primer

Developing a National Strategy for Serology (Antibody Testing) in the United States – The Johns Hopkins Center for Health Security

Advancing Access through Market Interventions: Lessons Learned from the GeneXpert Tuberculosis Test Buy-Down – David Branigan, Treatment Action Group, September 2020

A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease – Angkana T. Huang et al, Nature Communications, September 17, 2020

Ten reasons why immunity passports are a bad idea – Natalie Kofler & Françoise Baylis, Nature, May 21, 2020

What Antibody Studies Can Tell You — and More Importantly, What They Can’t – Caroline Chen, ProPublica, April 28

Treatment Action Group Statement on the High Price of Cepheid’s Xpert Test for COVID-19 – March 27, 2020 

Illustrated diagnostics glossary (pp.56-69) – Treatment Action Group

COVID-19 therapeutics tracker – Jeff Craven, Regulatory Focus

COVID-19 Treatment – University of Washington

Coronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health

Treatment Action Group Statement on HIV Treatments and SARS-CoV-2/COVID-19 – March 25, 2020

Treating COVID-19—Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics – Andre C. Kalil, JAMA, March 24, 2020

COVID-19 Vaccine Cheat Sheet—AVAC

Emergency Use Authorization for Vaccines Explained – U.S. Food and Drug Administration (FDA)

UNICEF: COVID-19 Vaccine Market Dashboard

Advocates Guide to COVID-19 Vaccine Access

DRAFT landscape of COVID-19 candidate vaccines – World Health Organization

Coronavirus Vaccine Tracker – New York Times

COVID-19 Vaccine Tracker – Jeff Craven, Regulatory Focus

VAXMAP: An open source-based map of COVID-19 candidate vaccines and manufacturing capacity

Making a vaccine accessible: A glossary of terms – Devex

Protecting Global Gains – a partnership of concerned advocates dedicated to sharing the innovative approaches that are helping communities combat COVID-19 without losing ground in other areas.

COVID Advocates Advisory Board

Essential Principles & Practices for GPP Compliance: Engaging stakeholders in biomedical research during the era of COVID-19 – AVAC

Good Participatory Practice (GPP) Guidelines – AVAC

Good Participatory Practice Guidelines for Trials of Emerging (And Re-emerging) Pathogens that are Likely to Cause Severe Outbreaks in the Near Future and for Which Few or No Medical Countermeasures Exist – World Health Organization

Good Participatory Practice for COVID-19 clinical trials: a toolbox – World Health Organization

Engage: Global Connections to Build Capacity – AVAC

Toolbox for Conducting Community-Engaged Research – The Scripps Institute

Community-Engaged Research – UCSF

The Communication Initiative Network

Science, theory, and practice of engaged research: Good Participatory Practice and beyond – Journal of the International AIDS Society, October 2018

Coronavirus COVID-19 Global Cases – Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)

The COVID Tracking Project

COVID-19 Projections Using Machine Learning – Youyang Gu

COVID Explained

COVID Timeline—Make Medicines Affordable